Cilostazol disrupts TLR-4, Akt/GSK-3β/CREB, and IL-6/JAK-2/STAT-3/SOCS-3 crosstalk in a rat model of Huntington's disease
about
Cilostazol disrupts TLR-4, Akt/GSK-3β/CREB, and IL-6/JAK-2/STAT-3/SOCS-3 crosstalk in a rat model of Huntington's disease
description
article publié dans la revue scientifique PLoS ONE
@fr
im Januar 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in PLoS ONE
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
Cilostazol disrupts TLR-4, Akt ...... model of Huntington's disease
@en
Cilostazol disrupts TLR-4, Akt ...... model of Huntington's disease
@nl
type
label
Cilostazol disrupts TLR-4, Akt ...... model of Huntington's disease
@en
Cilostazol disrupts TLR-4, Akt ...... model of Huntington's disease
@nl
prefLabel
Cilostazol disrupts TLR-4, Akt ...... model of Huntington's disease
@en
Cilostazol disrupts TLR-4, Akt ...... model of Huntington's disease
@nl
P2093
P2860
P1433
P1476
Cilostazol disrupts TLR-4, Akt ...... model of Huntington's disease
@en
P2093
Dalia M El-Tanbouly
Mai A Abd El Fattah
Walaa Wadie
P2860
P304
P356
10.1371/JOURNAL.PONE.0203837
P407
P577
2018-09-27T00:00:00Z